Freeline Therapeutics Holdings Stock Last Dividend Paid
FRLNDelisted Stock | USD 4.31 0.28 6.10% |
Freeline Therapeutics Holdings fundamentals help investors to digest information that contributes to Freeline Therapeutics' financial success or failures. It also enables traders to predict the movement of Freeline Stock. The fundamental analysis module provides a way to measure Freeline Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Freeline Therapeutics stock.
Freeline |
Freeline Therapeutics Holdings Company Last Dividend Paid Analysis
Freeline Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Freeline Therapeutics Holdings has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
Freeline Fundamentals
Return On Equity | -1.01 | |||
Return On Asset | -0.56 | |||
Current Valuation | 2.78 M | |||
Shares Outstanding | 4.36 M | |||
Shares Owned By Insiders | 1.09 % | |||
Shares Owned By Institutions | 45.88 % | |||
Number Of Shares Shorted | 23.93 K | |||
Price To Book | 0.94 X | |||
Price To Sales | 45.40 X | |||
Revenue | 622 K | |||
EBITDA | (64.84 M) | |||
Net Income | (49.93 M) | |||
Cash And Equivalents | 90 M | |||
Cash Per Share | 1.38 X | |||
Total Debt | 5.92 M | |||
Debt To Equity | 0.64 % | |||
Current Ratio | 3.68 X | |||
Book Value Per Share | 6.89 X | |||
Cash Flow From Operations | (64.24 M) | |||
Short Ratio | 1.92 X | |||
Earnings Per Share | (11.40) X | |||
Target Price | 8.25 | |||
Number Of Employees | 152 | |||
Beta | 0.66 | |||
Market Capitalization | 28.24 M | |||
Total Asset | 86.64 M | |||
Retained Earnings | (445.35 M) | |||
Working Capital | 36.66 M | |||
Z Score | -6.29 | |||
Net Asset | 86.64 M |
About Freeline Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Freeline Therapeutics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Freeline Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Freeline Therapeutics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Freeline Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Freeline Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freeline Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Freeline Stock
0.78 | KB | KB Financial Group | PairCorr |
0.67 | HPQ | HP Inc | PairCorr |
0.64 | INTC | Intel Aggressive Push | PairCorr |
0.63 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.43 | CSCO | Cisco Systems | PairCorr |
The ability to find closely correlated positions to Freeline Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Freeline Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Freeline Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Freeline Therapeutics Holdings to buy it.
The correlation of Freeline Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Freeline Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Freeline Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Freeline Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Freeline Stock
If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |